Economie AlgemeenIn een artikel op Deep Journal passeren een aantal merkwaardige feiten de revue. Hieruit valt op te maken dat tot nog toe niemand weet wat het effect van de vaccinatie tegen het N1H1 virus op mensen is op lange termijn. De vaccinatie tegen N1H1 moest heel snel in elkaar gedraait worden om zo een 'zogenaamde' pandemie te voorkomen. Het enige dat zeker is dat de farmaceutische industrie er een leuk zakcentje mee verdient heeft.
Despite promises that the Swine Flu vaccine is safe, it has not been tested on the target demographic that is now receiving the shots in Europe. The testing phase began the moment the drug became available and was administered to the public. It actually has been tested, but only on a small group of healthy people. This was done in a very short period of time. The long-term effects to all parties involved are unknown.
...
'A drug that is not approved, and is thus not safe, is not going to be released to the general public', said Klink'. But Klink knows that an exception to this rule has been made for the Swine Flu vaccine.
...
Prior to wide-scale distribution, it is tested for a short time on small groups of people and on animals.
...
'There is currently no clinical experience with Focetria (H1N1) in adults, including the elderly, children or adolescents. [...] There are currently no data available on the use of Focetria in pregnancy'
...
Nobody knows what the vaccine's long-term effect on the human body is. The EMEA doesn't know it, the manufacturer doesn't know it, and the [Dutch] National Health Council doesn't know it either.